О компании

Oryzon Genomics, S.A. is a clinical-stage biopharmaceutical company & the European leader in the development of epigenetics-based therapeutics, with strong focus on personalized medicine approaches to CNS disorders and oncology.

ES
Неизвестно
Не проверенная компания